PT-141 is a compounded peptide that a licensed provider can prescribe to one or both partners in a relationship. Many couples ask about it together when low desire or difficulty with arousal has become a shared frustration rather than one person's problem. Whether it fits your relationship depends on each partner's own health history. The right first step is an evaluation through telos rx, not a shared assumption about what will help.
Yes, couples can both use PT-141, but each partner needs a separate evaluation. PT-141 works on the central nervous system pathways tied to sexual desire in both men and women, so it is not exclusive to one sex. A provider reviews each person's health history on its own merits before deciding whether it is an appropriate option, and approval is not guaranteed for either partner.
Start your intake →Why couples look into PT-141 together
Low sexual desire rarely sits with only one partner. When one person's interest drops, the other partner often feels it too, whether as rejection, distance, or simple confusion about what changed. Some couples come looking for a shared answer rather than treating it as one partner's private issue to solve alone.
PT-141, also known by its generic name bremelanotide, is a melanocortin receptor agonist. Early research and the proposed mechanism suggest it acts on desire pathways in the brain rather than on blood flow the way some other sexual health approaches do. That is part of why it gets raised in the context of both partners, since desire itself, not just physical response, is often the shared concern.
It is worth being direct about scope. PT-141 is not a couples therapy replacement, and it will not resolve a relationship issue that has nothing to do with biology. It addresses one physiological piece of a much larger picture. A licensed provider is the right person to help sort out whether that piece applies to either partner, and whether a broader conversation is also warranted.
Does PT-141 work differently for each partner?
PT-141 is not gendered in how it is studied or prescribed. Bremelanotide's proposed mechanism involves melanocortin receptors tied to central arousal pathways. Early research has looked at this mechanism in both men and women, and telos rx providers evaluate men and women through the same process. You can read more on the PT-141 page before starting an intake.
That said, each partner's history is reviewed independently. A person's cardiovascular history, current medications, and other health factors matter more than which partner is asking. Two people in the same household can get two very different answers from a provider, and that is normal rather than a sign anything went wrong with the process.
If one partner is approved and the other is not, that is a clinical decision based on individual health information, not a judgment about desire or commitment. Your provider can walk through the reasoning if that happens.
Key takeaway: PT-141 is evaluated per person, not per couple. Both partners can start an intake, but each one goes through its own asynchronous review with a licensed provider.
Starting the conversation as a couple
If you and your partner want to look into PT-141 together, start with an honest conversation about what each of you is hoping changes. Some couples are focused on desire. Others care more about the overall experience of intimacy. Being clear about that helps a provider understand what you are asking for.
From there, each partner completes a separate online intake. The intake asks about health history, current medications, and relevant symptoms. It is asynchronous, meaning you fill it out on your own schedule rather than booking a live appointment, and a US-licensed provider reviews it afterward, often within hours.
Neither partner needs to wait for the other. If you complete your intake today and your partner completes theirs next week, each moves through review independently. There is no requirement that both start or finish at the same time.
What a provider looks at for each partner
A provider reviewing a PT-141 intake is looking at whether the medication is a reasonable fit for that individual's health picture. That includes cardiovascular history, blood pressure, current medications, and any conditions that might make a melanocortin receptor agonist inappropriate.
Nausea and flushing are the most commonly reported effects, and a provider will talk through what to expect and how to manage them if a prescription is approved. This is general information, not medical advice, and does not replace guidance from your own provider, who can speak to your specific situation.
If either partner has a health condition that makes PT-141 unsuitable, the provider will say so and can discuss whether another approach fits better. Approval is subject to medical approval by a licensed provider, and it is not guaranteed for either person.
Talking about side effects together
One advantage of going through this as a couple is that you can support each other through the early adjustment period. Nausea and flushing are the effects most people notice, particularly after a first dose, and knowing that in advance tends to make the experience less alarming for both partners.
If one partner experiences side effects and the other does not, that is common. Individual response varies, and it does not mean anything went wrong with dosing or timing. Message your care team through telos rx if either partner has a reaction that concerns you, since asynchronous messaging means you do not need to book a new appointment to ask.
Being upfront with each other about how you are feeling, physically and otherwise, tends to make the early weeks easier to navigate. Treating it as a private matter each partner manages alone usually makes the adjustment period harder than it needs to be.
Setting realistic shared expectations
It helps for couples to align on what they are actually expecting before starting. PT-141's proposed mechanism relates to desire signaling. It is not a fixed switch that produces the exact same experience for every person, or for both partners at once. The published evidence base for PT-141 outside its FDA-approved use is thinner than for more established medications. It is worth treating the early weeks as a period of finding out what, if anything, changes for each of you. Assuming a fixed timeline in advance tends to set couples up for disappointment.
Providers typically suggest giving a protocol some time before drawing conclusions, and adjusting from there based on what each partner reports. Quarterly labs and ongoing messaging with your care team are part of the plan, so this is a monitored process rather than a one-time decision.
If expectations do not match reality after a reasonable trial period, that is worth raising with your provider rather than quietly discontinuing. There may be a dose or approach adjustment worth trying before concluding it is not a fit.
Cost when both partners start treatment
PT-141 through telos rx starts from $5 a day, and that pricing applies per person, since each partner has their own prescription and plan. Each plan includes free 2-day shipping, unlimited messaging with your care team, quarterly labs, and dose adjustments as needed, with the ability to cancel anytime with no fee. If a provider declines to prescribe after evaluation, you pay nothing for that visit.
Plans are also FSA and HSA eligible, which can reduce the practical cost for either or both partners depending on your accounts. Start your own intake to see what applies to your situation, since costs and coverage are individual to each person's plan.
When PT-141 might not be the shared answer
Sometimes a couple looks into PT-141 and a provider determines it is not the right fit for one or both partners. That can happen for cardiovascular reasons, current medication interactions, or other health factors uncovered during intake.
It is also worth being honest that not every difficulty with intimacy has a biological driver that a peptide can address. Stress, relationship dynamics, and other factors matter. A provider may suggest that alongside or instead of a medication conversation. Telos rx providers can only evaluate the medical piece. A broader conversation with a couples counselor or therapist may be a useful parallel step if that is where the underlying issue sits.
If PT-141 is not appropriate for one partner, telos rx also offers evaluations for other options. Some couples look into sermorelin for broader wellness goals, NAD+ nasal spray for energy-related concerns, or BPC-157 for recovery-related concerns, if either partner's provider thinks one of those is worth discussing. None of these substitute for a PT-141 evaluation on its own page, they are simply other avenues telos rx providers can walk through if relevant.
Frequently Asked Questions
Can my partner and I both get PT-141 through telos rx?
Yes. Each partner completes a separate online intake and is reviewed individually by a US-licensed provider. Approval for one partner does not guarantee approval for the other, since each evaluation is based on that person's own health history.
Is PT-141 only for men or only for women?
Neither. PT-141, generically bremelanotide, has been studied in both men and women and telos rx evaluates both sexes through the same intake process. It is not restricted to one gender.
Do we need to start our intakes on the same day?
No. Each partner can start and complete their intake on their own schedule. Review happens asynchronously, so there is no requirement to be in sync with your partner's timeline.
What if only one of us is approved?
That can happen, and it reflects individual health history rather than anything about your relationship. Your provider can explain the reasoning, and the partner who was not approved can discuss other options during their visit.
Will PT-141 fix a relationship issue?
PT-141 addresses a physiological pathway related to desire signaling, not relationship dynamics themselves. If the underlying concern is emotional or relational, a provider may suggest that alongside, or instead of, a medication conversation.
How much does it cost if both partners start treatment?
PT-141 through telos rx starts from $5 a day per person, since each partner has an individual prescription and plan. Each plan includes shipping, messaging, quarterly labs, and the ability to cancel anytime with no fee.
Telos rx is LegitScript-certified. PT-141 is compounded medication and is not FDA-approved. It is prepared by partner compounding pharmacies in the United States, and any prescription is subject to medical approval by a licensed provider. This article is general information, not medical advice, and does not replace guidance from your own provider. Approval is not guaranteed. For general background on melanocortin receptor agonists, see the NIH-indexed research on melanocortin agonists for sexual dysfunction. For how compounded medication is regulated, see the FDA overview of drug compounding.
Curious whether PT-141 could be right for you and your partner? Start your online visit at telos rx.